GRAMD1B antibodies are polyclonal or monoclonal reagents targeting the GRAMD1B protein, encoded by the GRAMD1B gene (NCBI Gene ID: 57476). Key features include:
Property
Detail
Immunogen
Recombinant GRAMD1B fusion protein (e.g., residues RFKMRRMKNVQEQSLEAGLARDLPAVLAPGKEFLQLPSIEITPSSDEDTPWSNCSTPSASPRRKRFLLRKWLRVRERKECSESSSSLRI)
Host Species
Rabbit (common source for polyclonal antibodies)
Reactivity
Human, mouse (validated via Western blot, IHC, immunofluorescence)
Molecular Weight
~85 kDa (observed); 86.5 kDa (calculated)
Isoforms
Four validated isoforms (694–745 amino acids) with truncated N-/C-terminal regions
Key Domains
GRAM Domain (aa 100–194): Binds phosphatidylserine and regulates cholesterol sensing.
Typically, we can ship products within 1-3 business days after receiving your order. Delivery timelines may vary depending on the purchase method or location. Please consult your local distributor for specific delivery details.
Synonyms
GRAMD1B; KIAA1201; UNQ3032/PRO9834; Protein Aster-B; GRAM domain-containing protein 1B
GRAMD1B Antibody targets GRAMD1B, a cholesterol transporter responsible for non-vesicular cholesterol transfer from the plasma membrane (PM) to the endoplasmic reticulum (ER). GRAMD1B possesses unique domains for cholesterol and PM binding, acting as a molecular bridge facilitating cholesterol movement between these membranes. It plays a vital role in maintaining cholesterol homeostasis within the adrenal gland, exhibiting a unique ability to localize to the PM based on membrane cholesterol levels. In lipid-deficient conditions, GRAMD1B localizes to the ER membrane. However, in response to excess cholesterol in the PM, it is recruited to the endoplasmic reticulum-plasma membrane contact sites (EPCS) via its GRAM domain. At the EPCS, the sterol-binding VASt/ASTER domain binds to cholesterol within the PM, facilitating its transfer from the PM to the ER.